QBI and the Scientific Department of the Embassy of France in the United States present "AI, Big Data and Health", a science fair that will take place virtually on November 9-10 and 12-13, 2020 from 8:00 - 10:00 AM. This science fair aims to bring together different actors from industry, academia, and government from the United States and France to talk about Big Data and AI applications for health.

The application of Artificial Intelligence to health and health data management is one of the areas where the creation of start-ups and the emergence of new technological solutions is massively increasing, in the United States as in France, supported by renowned research institutions. The applications are multiple: aid in diagnosis, analysis of exams, in particular in imaging, contribution to the discovery of new therapeutic targets and molecules. This requires multidisciplinary approaches that involve strengthening the interfaces between experts with very different profiles: AI specialists, researchers in biology and health, doctors, regulators, businesses and patients. These increasingly concrete developments require a reflection in terms of ethics and regulation (legal responsibility, risks potential, influence of AI on the doctor, management of learning data, bias and discrimination). To address these different aspects, this event aims to bring together different experts through a virtual Science Fair open to the general public to discuss these topics within framework of a Franco-American cooperation.

November 13, 2020

8:00AM PT, 5:00PM CET - PANEL 5: "AI & Pharma : protein folding and protein interactions, exploring all the possibilities"

Panel Description: Moderated by Kaspar Mossman, the panel will discuss the application of big data to drug discovery.

Moderator: Kaspar Mossman - QB3/UCSF, Director of Communications and Marketing

Julien Mamet - Adynxx, Inc., Founder

Brice Gaudillière - Stanford, Associate Professor

Jim Bosley - Novadiscovery, Sr. Vice President of Modeling

Kliment A Verba - QBI/UCSF, Fellow, Dept of Pharmaceutical Chemistry

Michelle Arkin - QBI/UCSF, Professor, Pharmaceutical Chemistry; Co-Director of the Small Molecule Discovery Center

Natalia Jura - QBI/UCSF, Associate Professor, Cardiovascular Research Institute

9:00AM PT, 6:00PM CET - PANEL 6: "Immunotherapy and the rise of personalized medicine"

Panel Description: Moderated by the UCSF President of the Helen Diller Family Comprehensive Cancer Center, Alan Ashworth, the discussion will focus on cancer immunotherapy and precision medicine.

Moderator/Speaker: Alan Ashworth - QBI/UCSF, Professor, Medicine; Senior Vice President for Cancer Services; President of Helen Diller Family Comprehensive Cancer Center

Sophie Vinay-Postel - Institut Gustave Roussy, Physician; Fellow

Alejandro Sweet-Cordero - UCSF, Director, Molecular Oncology Initiative, Professor of Pediatrics

Lawrence Fong - UCSF, Professor, Medicine